TransMedics Gr Q2 EPS $0.35 Beats $0.21 Estimate, Sales $114.31M Beat $98.97M Estimate
TransMedics Gr Q2 EPS $0.35 Beats $0.21 Estimate, Sales $114.31M Beat $98.97M Estimate
transmedics第二季每股收益为0.35美元，超出了0.21美元的预估，销售额为1.1431亿美元，超出了0.9897亿美元的预估。
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.21 by 66.67 percent. This is a 1266.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $114.31 million which beat the analyst consensus estimate of $98.97 million by 15.49 percent. This is a 117.87 percent increase over sales of $52.47 million the same period last year.
TransMedics Gr（纳斯达克股票代码：TMDX）报告每股盈利0.35美元，超过分析师预期的0.21美元，增长66.67％。这比去年同期每股亏损0.03美元增长了1266.67％。该公司本季度销售额为1,1431万美元，超过分析师预期的9897万美元，增长15.49％。这比去年同期销售额为5247万美元增长了117.87％。